Ramana Kuchibhatla, Ph.D.

Ramana Kuchibhatla received a B.Sc. {Hons} in mathematics and a M.Sc. in applied statistics from the Osmania University in Hyderabad, India. He worked at ICMR's Institute for Research in Medical Statistics in Madras in public health and health statistics before joining the Administrative Staff College of India in Hyderabad as a faculty member in the Center for Energy, Environment & Technology. He was recruited by the University of Iowa to join the Graduate Program in Geography to major in quantitative methods and environmental studies. He received his M.A. and Ph.D. from the University of Iowa, Iowa City, IA, USA.

He worked at ManTech Environmental Technology, Inc. a private consulting company specializing in environmental and health assessments where he studied cancer risks of agricultural chemicals.

His pharmaceutical career began in 1996 with Glaxo Wellcome (now GlaxoSmithKline) where he consulted in Biostatistics and later in clinical research and development in the neurology and psychiatry therapeutic area. During his tenure, he was involved in the successful filing of two sNDAs that brought Zyban® and Lamictal® to market.

In 2001, he joined Targacept, Inc. as director of clinical research and development to help set up clinical operations and later assumed management of not only clinical development but also biostatistics and data management functions at Targacept Inc.

In April 2007, Kuchibhatla left Targacept and founded Ventureast Pharmaceutical Services, LLC based in North Carolina, USA and QED Pharmaceutical Services Pvt Ltd. located in Hyderabad, India to offer integrated clinical research services to the pharmaceutical companies.